For U.S. residents Ages 18+ Only
Take The Quiz
Events Stay Connected

SYSTEMIC MASTOCYTOSIS EMAIL SIGNUP

THERE’S SO MUCH MORE TO LEARN. DON’T MISS A THING.

White Woman Holding Book

Not an actual patient

CONNECT WITH US

There are other people, like you, who are searching to explain their symptoms. Making connections may be a source of validation, strength, and understanding. Sign up for emails from Blueprint Medicines to learn more about SM, community events, talking with your doctor, and Blueprint Medicines.

Email Sign-up
Form
All fields required.
I would like to receive emails from Blueprint Medicines regarding its products, services, promotions, helpful tools and resources. I consent to Blueprint Medicines and its service providers using my personal information, including health-related details, to send me additional information regarding its products, services, and promotions, but can unsubscribe at any time by clicking "Unsubscribe" link in its emails.
I have not been diagnosed with SM by a doctor
I have been diagnosed with Indolent Systemic Mastocytosis (ISM)
I have been diagnosed with Advanced SM (ASM, SM-AHN, MCL)
I'm a caretaker for someone with SM
I am not sure/rather not answer
By clicking Submit, I confirm that I am 18 years or older, am a U.S. resident, and have read and agree to Blueprint Medicines' Terms of Use. I have read and agree to Blueprint Medicines' privacy practices, including how it processes, shares and protects personal information, as listed in its Privacy Notice.
SUBMIT
Privacy Notice Terms of Use Sitemap
Do Not Sell Or Share My Personal Information Limit The Use Of My Sensitive Information
Consumer Health Data Privacy Notice Supplement

This website does not provide medical advice and is for educational purposes only.

Blueprint Medicines is a biopharmaceutical company studying oncology, hematology, and rare diseases.

Blueprint Medicines and associated logo are trademarks of Blueprint Medicines Corporation.

All other trademarks are the property of their respective owners.

© 2025 Blueprint Medicines Corporation.

06/2025  USBP-PRNP-21.001.6